Acetal Resin
Deviceoverdenture supported by implants
NCT Number: NCT07666763
Objective: To evaluate and compare the effect of two different attachment housing materials-Acetal Resin (Polyoxymethylene) versus conventional Nylon elastic caps-on marginal crestal bone loss around dental implants supporting a mandibular overdenture. It also evaluates peri-implant clinical tissue health by measuring pocket depth and the gingival bleeding index.
Trial opening soon.
Get Notified40 year–60 year
Male
Interventional
Not applicable
Study Design & Timeline: A prospective, double-blind, randomized controlled clinical trial with a 1:1 allocation ratio. Clinical and radiographic outcomes will be evaluated at overdenture insertion (baseline), and at 6 and 12 months post-insertion.ethodology & Analysis: Pre-operative bone volume will be assessed via Cone Beam CT (CBCT). Crestal bone loss will be measured using the long cone parallel radiographic technique , while pocket depth and gingival bleeding will be measured using a William's graduated probing device. Data will undergo normality testing to determine the use of parametric (Independent t-test, Repeated Measures ANOVA) or non-parametric (Mann-Whitney, Friedman) statistical analyse
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
overdenture supported by implants
overdenture supported by implants
Time frame: one year
mm
Time frame: one year
mm
Future University in Egypt
Other
Acronym: AcetalResin
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04670965
Bone Diseases, Bone Diseases, Metabolic
Birmingham, Alabama, United States
View Trial DetailsNCT07540156
Bone Defects, Bone Diseases
Hanoi, Vietnam
View Trial DetailsNCT07196228
Bone Diseases, Bone Diseases, Metabolic
View Trial DetailsNCT06935747
Bone Diseases, Bone Diseases, Metabolic
Santiago de Compostela, A Coruña, Spain
View Trial Details